T/CACM 1267-2019 Active Group standards

T/CACM 1267-2019 Chinese Internal Medicine Clinical Guidelines for the Diagnosis and Treatment of Hepatic Fibrosis

Publish Date: 2019-01-30 Implement Date: 2020-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CACM 1267-2019

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Medicine

ICS Name: Comprehensive Pharmaceutical Science

Publish Date: 2019-01-30

Implement Date: 2020-01-01

Scope

Main technical content: This guideline proposes the diagnosis of liver fibrosis, the treatment based on syndrome differentiation, traditional Chinese medicine external treatment methods, and prevention and care recommendations. This guideline is applicable to the diagnosis and prevention of liver fibrosis in people aged 18 and above. This guideline is suitable for clinicians in relevant departments such as hepatology, infectious diseases, digestive medicine, traditional Chinese medicine, integrated traditional and Western medicine, and grassroots doctors in traditional Chinese medicine